Chronic kidney disease Japan cohort (CKD-JAC) Study: Design and methods

Enyu Imai, Seiichi Matsuo, Hirofumi Makino, Tsuyoshi Watanabe, Tadao Akizawa, Kosaku Nitta, Satoshi Iimuro, Yasuo Ohashi, Akira Hishida

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

The prevalence and incidence of end-stage renal disease (ESRD) in Japan are the highest and the third highest, respectively, in the world, while the incidence of cardiac death in Japan is the lowest among developed countries. A recent study showed that the prevalence of chronic kidney disease (CKD), defined as an estimated glomerular filtration rate (GFR) of less than 60 mL/min/1.73 m2, is extremely high in Japan, about 20% of the adult population. However, the risk of ESRD and cardiovascular disease (CVD) in the CKD population has not been determined nationwide. For this observational study, we will establish a Chronic Kidney Disease Japan Cohort (CKD-JAC) by enrolling 3,000 patients with CKD in 17 clinical centers around Japan, which will be used to determine the incidence of ESRD and CVD in Japanese CKD patients. Risk factors associated with the development of CVD will also be examined. Comorbidity of diabetes in CKD patients will be analyzed to determine whether it is a risk for rapid progression of CKD and high incidence of CVD. In addition, we will study whether the burden of CKD decreases the QOL of patients, and increases hospitalization or health resource utilization. Insights from the CKD-JAC study will provide a basis for future interventional trials focused on reducing the burden of ESRD and CVD in patients with CKD in Japan.

Original languageEnglish
Pages (from-to)1101-1107
Number of pages7
JournalHypertension Research
Volume31
Issue number6
DOIs
Publication statusPublished - Jun 1 2008

Fingerprint

Chronic Renal Insufficiency
Japan
Cohort Studies
Cardiovascular Diseases
Chronic Kidney Failure
Incidence
Health Resources
Glomerular Filtration Rate
Developed Countries
Population
Observational Studies
Comorbidity
Hospitalization
Cross-Sectional Studies

Keywords

  • Cardiovascular disease
  • Heart failure
  • Proteinuria
  • Stroke
  • Time to event analysis

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Imai, E., Matsuo, S., Makino, H., Watanabe, T., Akizawa, T., Nitta, K., ... Hishida, A. (2008). Chronic kidney disease Japan cohort (CKD-JAC) Study: Design and methods. Hypertension Research, 31(6), 1101-1107. https://doi.org/10.1291/hypres.31.1101

Chronic kidney disease Japan cohort (CKD-JAC) Study : Design and methods. / Imai, Enyu; Matsuo, Seiichi; Makino, Hirofumi; Watanabe, Tsuyoshi; Akizawa, Tadao; Nitta, Kosaku; Iimuro, Satoshi; Ohashi, Yasuo; Hishida, Akira.

In: Hypertension Research, Vol. 31, No. 6, 01.06.2008, p. 1101-1107.

Research output: Contribution to journalArticle

Imai, E, Matsuo, S, Makino, H, Watanabe, T, Akizawa, T, Nitta, K, Iimuro, S, Ohashi, Y & Hishida, A 2008, 'Chronic kidney disease Japan cohort (CKD-JAC) Study: Design and methods', Hypertension Research, vol. 31, no. 6, pp. 1101-1107. https://doi.org/10.1291/hypres.31.1101
Imai, Enyu ; Matsuo, Seiichi ; Makino, Hirofumi ; Watanabe, Tsuyoshi ; Akizawa, Tadao ; Nitta, Kosaku ; Iimuro, Satoshi ; Ohashi, Yasuo ; Hishida, Akira. / Chronic kidney disease Japan cohort (CKD-JAC) Study : Design and methods. In: Hypertension Research. 2008 ; Vol. 31, No. 6. pp. 1101-1107.
@article{9bc421d73ac8455ead8f41055986f96d,
title = "Chronic kidney disease Japan cohort (CKD-JAC) Study: Design and methods",
abstract = "The prevalence and incidence of end-stage renal disease (ESRD) in Japan are the highest and the third highest, respectively, in the world, while the incidence of cardiac death in Japan is the lowest among developed countries. A recent study showed that the prevalence of chronic kidney disease (CKD), defined as an estimated glomerular filtration rate (GFR) of less than 60 mL/min/1.73 m2, is extremely high in Japan, about 20{\%} of the adult population. However, the risk of ESRD and cardiovascular disease (CVD) in the CKD population has not been determined nationwide. For this observational study, we will establish a Chronic Kidney Disease Japan Cohort (CKD-JAC) by enrolling 3,000 patients with CKD in 17 clinical centers around Japan, which will be used to determine the incidence of ESRD and CVD in Japanese CKD patients. Risk factors associated with the development of CVD will also be examined. Comorbidity of diabetes in CKD patients will be analyzed to determine whether it is a risk for rapid progression of CKD and high incidence of CVD. In addition, we will study whether the burden of CKD decreases the QOL of patients, and increases hospitalization or health resource utilization. Insights from the CKD-JAC study will provide a basis for future interventional trials focused on reducing the burden of ESRD and CVD in patients with CKD in Japan.",
keywords = "Cardiovascular disease, Heart failure, Proteinuria, Stroke, Time to event analysis",
author = "Enyu Imai and Seiichi Matsuo and Hirofumi Makino and Tsuyoshi Watanabe and Tadao Akizawa and Kosaku Nitta and Satoshi Iimuro and Yasuo Ohashi and Akira Hishida",
year = "2008",
month = "6",
day = "1",
doi = "10.1291/hypres.31.1101",
language = "English",
volume = "31",
pages = "1101--1107",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Chronic kidney disease Japan cohort (CKD-JAC) Study

T2 - Design and methods

AU - Imai, Enyu

AU - Matsuo, Seiichi

AU - Makino, Hirofumi

AU - Watanabe, Tsuyoshi

AU - Akizawa, Tadao

AU - Nitta, Kosaku

AU - Iimuro, Satoshi

AU - Ohashi, Yasuo

AU - Hishida, Akira

PY - 2008/6/1

Y1 - 2008/6/1

N2 - The prevalence and incidence of end-stage renal disease (ESRD) in Japan are the highest and the third highest, respectively, in the world, while the incidence of cardiac death in Japan is the lowest among developed countries. A recent study showed that the prevalence of chronic kidney disease (CKD), defined as an estimated glomerular filtration rate (GFR) of less than 60 mL/min/1.73 m2, is extremely high in Japan, about 20% of the adult population. However, the risk of ESRD and cardiovascular disease (CVD) in the CKD population has not been determined nationwide. For this observational study, we will establish a Chronic Kidney Disease Japan Cohort (CKD-JAC) by enrolling 3,000 patients with CKD in 17 clinical centers around Japan, which will be used to determine the incidence of ESRD and CVD in Japanese CKD patients. Risk factors associated with the development of CVD will also be examined. Comorbidity of diabetes in CKD patients will be analyzed to determine whether it is a risk for rapid progression of CKD and high incidence of CVD. In addition, we will study whether the burden of CKD decreases the QOL of patients, and increases hospitalization or health resource utilization. Insights from the CKD-JAC study will provide a basis for future interventional trials focused on reducing the burden of ESRD and CVD in patients with CKD in Japan.

AB - The prevalence and incidence of end-stage renal disease (ESRD) in Japan are the highest and the third highest, respectively, in the world, while the incidence of cardiac death in Japan is the lowest among developed countries. A recent study showed that the prevalence of chronic kidney disease (CKD), defined as an estimated glomerular filtration rate (GFR) of less than 60 mL/min/1.73 m2, is extremely high in Japan, about 20% of the adult population. However, the risk of ESRD and cardiovascular disease (CVD) in the CKD population has not been determined nationwide. For this observational study, we will establish a Chronic Kidney Disease Japan Cohort (CKD-JAC) by enrolling 3,000 patients with CKD in 17 clinical centers around Japan, which will be used to determine the incidence of ESRD and CVD in Japanese CKD patients. Risk factors associated with the development of CVD will also be examined. Comorbidity of diabetes in CKD patients will be analyzed to determine whether it is a risk for rapid progression of CKD and high incidence of CVD. In addition, we will study whether the burden of CKD decreases the QOL of patients, and increases hospitalization or health resource utilization. Insights from the CKD-JAC study will provide a basis for future interventional trials focused on reducing the burden of ESRD and CVD in patients with CKD in Japan.

KW - Cardiovascular disease

KW - Heart failure

KW - Proteinuria

KW - Stroke

KW - Time to event analysis

UR - http://www.scopus.com/inward/record.url?scp=48349099380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48349099380&partnerID=8YFLogxK

U2 - 10.1291/hypres.31.1101

DO - 10.1291/hypres.31.1101

M3 - Article

C2 - 18716357

AN - SCOPUS:48349099380

VL - 31

SP - 1101

EP - 1107

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 6

ER -